object
studi
compar
system
local
cytokin
profil
neutrophil
respons
patient
sever
versu
nonsever
communityacquir
pneumonia
cap
hospit
patient
cap
group
accord
pneumonia
sever
index
psi
nonsever
psi
point
sever
point
blood
sputum
sampl
collect
upon
admiss
compar
nonsever
cap
patient
sever
cap
group
show
higher
plasma
level
proand
antiinflammatori
cytokin
contrast
lower
sputum
concentr
proinflammatori
cytokin
blood
neutrophil
function
respons
elev
cap
patient
compar
healthi
control
howev
neutrophil
sever
cap
patient
show
reduc
respiratori
burst
activ
compar
nonsever
group
result
indic
patient
sever
cap
fail
mount
robust
local
proinflammatori
respons
exhibit
instead
substanti
system
inflammatori
respons
suggest
key
driver
cap
sever
may
abil
patient
gener
optim
local
inflammatori
respons
communityacquir
pneumonia
cap
one
major
infecti
diseaserel
caus
death
develop
underdevelop
countri
cap
initi
inflammatori
respons
elicit
resid
alveolar
macrophag
respons
invad
microorgan
cell
produc
cascad
proinflammatori
cytokin
chemokin
vigor
recruit
activ
blood
leukocyt
particularli
neutrophil
lung
play
major
role
curb
infect
hospit
cap
patient
sever
diseas
influenc
abil
immun
respons
control
pathogen
microorgan
well
regul
local
proinflammatori
respons
neutrophil
accumul
inflammatori
respons
neutrophil
undergo
sequenti
releas
variou
granul
subtyp
enhanc
respiratori
burst
activ
product
reactiv
oxygen
speci
potenti
rafael
fernandezbotran
silvia
uriart
contribut
equal
work
electron
supplementari
materi
onlin
version
articl
contain
supplementari
materi
avail
author
user
caus
tissu
damag
evid
suggest
failur
control
excess
inflamm
andor
neutrophil
activ
may
result
exagger
system
inflamm
organ
damag
lead
sever
diseas
data
examin
associ
local
inflammatori
respons
sever
diseas
limit
sinc
sever
cap
associ
significantli
higher
mortal
nonsever
cap
better
understand
local
system
inflammatori
respons
hospit
patient
sever
cap
may
necessari
develop
novel
strategi
manag
patient
object
studi
character
contrast
lung
system
cytokin
profil
well
blood
neutrophil
respons
patient
sever
versu
nonsever
cap
time
hospit
admiss
prospect
observ
studi
hospit
patient
cap
univers
louisvil
hospit
veteran
administr
hospit
univers
louisvil
human
subject
program
protect
offic
robley
rex
veteran
affair
medic
center
institut
review
board
approv
studi
prior
data
collect
approv
no
respect
inclus
criteriacriteria
cap
patient
cap
defin
evid
new
pulmonari
infiltr
chest
radiograph
associ
least
one
follow
new
increas
cough
fever
hypothermia
leukocytosi
left
shift
leucopenia
includ
studi
follow
previou
written
consent
inclus
exclus
criteria
full
case
report
form
studi
found
commun
acquir
pneumonia
organ
studi
site
wwwcapositecom
exclus
criteria
unstabl
psychiatr
psycholog
condit
render
subject
unlik
cooper
complet
studi
requir
patient
exclud
medic
histori
opinion
preclud
subject
complianc
protocol
immunosuppress
part
exclus
criteria
none
patient
includ
studi
neutropen
neutrophilsmm
healthi
control
group
order
compar
result
plasma
cytokin
neutrophil
function
assay
cap
patient
healthi
individu
blood
sampl
also
obtain
control
group
healthi
adult
donor
approv
univers
irb
microbiolog
analysi
test
sputum
sampl
blood
cultur
tracheal
aspir
pleural
fluid
serolog
respiratori
virus
atyp
organ
urinari
antigen
legionella
spp
streptococcu
pneumonia
perform
accord
standard
clinic
practic
identif
microorgan
suscept
test
perform
accord
standard
method
sever
diseas
one
commonli
use
predict
score
psi
use
studi
defin
cap
sever
hospit
patient
consid
sever
cap
psi
risk
class
ivor
v
point
higher
patient
psi
risk
class
iiii
point
defin
nonsever
cap
plasma
sampl
blood
sampl
obtain
day
admiss
hospit
venou
blood
collect
use
sodium
citrat
vacutain
tube
follow
centrifug
min
plasma
separ
aspir
aliquot
store
frozen
assay
sputum
sampl
sputum
sampl
collect
total
cap
patient
nonsever
sever
cap
day
admiss
hospit
patient
instruct
rins
mouth
water
collect
spontaneouslyproduc
sputum
steril
dispos
polypropylen
centrifug
tube
sampl
kept
transport
laboratori
within
h
collect
sputum
sampl
process
follow
method
describ
pizzichini
et
al
upon
receipt
sputum
sampl
dilut
equal
amount
dithiothreitol
dtt
solut
pb
incub
rock
platform
min
order
digest
mucu
equal
volum
steril
salin
ad
follow
addit
min
incub
sampl
filter
nylon
gauz
centrifug
min
cellfre
supernat
aliquot
store
frozen
use
measur
cytokin
level
concentr
interleukin
il
receptor
antagonist
interferon
ifn
tumor
necrosi
factor
tnf
plasma
sputum
sampl
determin
use
milliplex
map
multiplex
kit
emd
millipor
billerica
follow
thaw
plasma
process
sputum
sampl
centrifug
min
supernat
use
assay
accord
instruct
order
control
potenti
interfer
dtt
contain
sputum
sampl
measur
differ
cytokin
multiplex
assay
evalu
effect
dtt
run
sampl
known
cytokin
concentr
presenc
absenc
dtt
final
concentr
sputum
sampl
eight
ten
cytokin
measur
littl
interfer
measur
presenc
dtt
averag
within
control
case
measur
presenc
dtt
show
averag
reduct
compar
control
comparison
cytokin
level
sputum
sampl
differ
patient
group
sever
vs
nonsever
cap
perform
among
similarli
process
sampl
eg
presenc
dtt
neutrophil
function
assay
perform
use
whole
blood
sampl
basal
formylmethionylleucylphenylalanin
fmlf
stimul
exocytosi
determin
measur
plasma
membran
express
secretori
vesicl
clone
specif
granul
clone
biolegend
san
diego
ca
facscalibur
instrument
becton
dickinson
franklin
lake
nj
follow
antibodi
treatment
red
cell
lyse
bd
red
cell
lysi
buffer
becton
dickinson
follow
two
wash
sodium
azid
fixat
paraformaldehyd
analysi
phagocytosi
phagocytosisstimul
respiratori
burst
activ
measur
use
flow
cytometr
assay
base
product
h
stimul
phagocytosi
staphylococcu
aureu
previous
describ
briefli
neutrophil
cellsml
incub
diacet
final
concentr
min
aliquot
cell
suspens
sampl
min
addit
opson
propidium
iodidelabel
aureu
final
concentr
bacteriaml
fixat
paraformaldehyd
cell
analyz
phagocytosi
h
product
flow
cytometri
facscalibur
instrument
statist
analysi
perform
use
graphpad
prism
graphpad
softwar
la
jolla
ca
r
version
wwwrprojectorg
cytokin
neutrophil
data
present
median
intraquartil
rang
data
distribut
analyz
use
pearson
omnibu
normal
test
statist
comparison
group
perform
use
mannwhitney
test
correl
analys
perform
method
p
valu
consid
statist
signific
total
hospit
patient
cap
includ
studi
nonsever
sever
cap
group
made
patient
respect
main
demograph
medic
histori
clinicallaboratori
characterist
two
group
summar
tabl
statist
signific
differ
p
age
two
group
patient
sever
cap
group
median
age
year
vs
year
nonsever
cap
group
differ
gender
resid
nurs
home
observ
cerebrovascular
diseas
congest
heart
failur
copd
frequent
sever
cap
group
signific
differ
underli
condit
blood
urea
nitrogen
level
peripher
blood
neutrophil
count
higher
sever
cap
group
inhospit
mortal
rehospit
significantli
differ
group
patient
nonsever
cap
group
like
time
clinic
stabil
tc
less
day
compar
sever
cap
group
vs
respect
etiolog
agent
could
identifi
standard
laboratori
procedur
approxim
half
patient
group
patient
approxim
quarter
case
group
patient
etiolog
agent
identifi
pneumonia
tabl
plasma
cytokin
profil
group
shown
fig
data
tabl
form
supplementari
materi
tabl
gener
patient
sever
cap
group
show
pattern
median
plasma
concentr
proand
antiinflammatori
cytokin
higher
comparison
nonsever
cap
group
healthi
control
group
sever
cap
group
patient
median
plasma
concentr
approxim
twice
high
nonsever
cap
group
moreov
patient
either
group
undetect
concentr
plasma
pgml
measur
tend
higher
sever
cap
group
differ
median
concentr
two
group
statist
signific
p
cytokin
statist
signific
differ
found
case
antiinflammatori
iqr
interquartil
rang
partial
oxygen
pressur
bnp
brain
natriuret
peptid
bun
blood
urea
nitrogen
crp
creactiv
protein
wbc
white
cell
blood
count
rr
respiratori
rate
hr
heart
rate
bp
blood
pressur
tc
time
clinic
stabil
lo
length
stay
psi
pneumonia
sever
index
cytokin
similar
pattern
observ
median
concentr
cytokin
three
four
time
higher
sever
cap
group
p
final
median
concentr
adapt
immunityrel
cytokin
also
four
five
time
higher
sever
cap
group
p
sputum
cytokin
profil
shown
fig
data
tabl
form
supplementari
materi
tabl
concentr
cytokin
sputum
much
higher
pattern
mirror
observ
plasma
relat
sever
group
pattern
sputum
opposit
seen
plasma
sever
cytokin
median
valu
significantli
higher
nonsever
cap
group
particularli
proinflammatori
cytokin
exampl
median
concentr
respect
higher
sever
cap
group
p
p
howev
signific
differ
observ
antiinflammatori
cytokin
case
adaptiveimmunityrel
cytokin
median
concentr
found
also
higher
nonsever
cap
group
p
differ
observ
concentr
tabl
show
basal
fmlfstimul
express
granul
marker
well
respiratori
burst
activ
higher
cap
group
nonsever
sever
compar
healthi
donor
indic
neutrophil
primedpreactiv
cap
patient
comparison
nonsever
sever
cap
group
show
moder
statisticallysignific
higher
median
basal
level
differ
fmlfstimul
express
sever
cap
patient
contrast
patient
sever
cap
group
significantli
lower
median
level
respiratori
burst
activ
compar
nonsever
cap
group
analysi
potenti
correl
plasma
cytokin
level
neutrophil
function
studi
indic
moder
statist
signific
posit
correl
tabl
neutrophil
respiratori
burst
plasma
level
sampl
analyz
fig
studi
indic
time
hospit
admiss
patient
sever
cap
decreas
local
inflammatori
respons
exagger
system
inflammatori
respons
compar
patient
nonsever
cap
observ
suggest
patient
sever
cap
may
lower
suboptim
lung
inflammatori
respons
result
inabl
control
microbi
invas
local
level
analysi
plasma
cytokin
respons
found
patient
sever
cap
present
significantli
higher
level
proand
antiinflammatori
cytokin
argu
potenti
skew
system
respons
toward
antiinflammatori
immunosuppress
cytokin
although
expect
higher
system
level
proand
antiinflammatori
cytokin
would
correl
sever
pneumonia
found
hospit
patient
nonsever
cap
significantli
higher
level
proinflammatori
cytokin
sputum
interestingli
signific
differ
two
group
observ
sputum
concentr
chemokin
antiinflammatori
cytokin
taken
togeth
observ
suggest
local
sputum
proinflammatori
respons
hospit
patient
nonsever
cap
robust
hospit
patient
sever
cap
despit
activ
statu
neutrophil
hospit
patient
cap
compar
healthi
control
neutrophil
patient
sever
cap
show
moder
significantli
reduc
level
respiratori
burst
activ
compar
patient
nonsever
cap
consist
reduc
bactericid
capac
inabl
control
bacteri
infect
inde
reduc
neutrophil
respiratori
burst
activ
report
case
sepsi
caus
reduc
respiratori
burst
hospit
patient
sever
cap
clear
nevertheless
posit
statist
signific
correl
found
neutrophil
respiratori
burst
activ
system
level
interest
role
ro
activ
signal
mechan
includ
phosphoryl
involv
secret
report
moreov
reduc
product
may
also
correl
decreas
abil
attract
lymphocyt
particularli
subset
lung
therefor
compromis
abil
adequ
control
infect
studi
line
previou
report
posit
associ
higher
serum
proinflammatori
antiinflammatori
cytokin
level
measur
pneumonia
sever
pneumonia
sever
index
crb
score
howev
find
higher
proinflammatori
cytokin
level
sputum
nonsever
vs
sever
cap
patient
knowledg
previous
report
studi
paat
et
al
found
significantli
higher
level
bronchoalveolar
lavag
bal
fluid
pneumonia
patient
compar
healthi
control
correl
diseas
sever
score
psi
howev
clear
close
cytokin
level
sputum
correl
bal
heavi
predomin
neutrophil
sputum
compar
bal
cytokin
level
former
may
repres
neutrophil
respons
separ
studi
lee
et
al
find
significantli
higher
level
bal
patient
sever
cap
die
versu
surviv
comparison
studi
possibl
sinc
patient
analyz
studi
sever
cap
studi
rel
number
patient
sputum
sampl
limit
abil
studi
gener
prevent
adjust
confound
effect
anoth
potenti
limit
studi
inclus
cap
patient
differ
microbi
etiolog
report
differ
microorgan
may
elicit
differ
cytokin
activ
pattern
cap
lowest
inflammatori
pattern
associ
cap
unknown
etiolog
highest
pneumonia
enterobacteriacea
use
psi
score
defin
sever
cap
without
limit
recent
metaanalysi
indic
commonlyus
score
psi
previous
deriv
valid
predict
mortal
moder
perform
predict
icu
admiss
moreov
need
remark
sever
factor
influenc
psi
score
may
direct
effect
inflammatoryimmun
respons
thu
partial
respons
observ
result
two
psibas
sever
group
differ
significantli
term
age
sever
comorbid
age
known
affect
immun
function
multipl
level
innat
adapt
immun
respons
compromis
increas
age
multipl
studi
mice
human
analyz
effect
senesc
macrophag
neutrophil
main
cell
involv
innat
respons
cap
gener
macrophag
neutrophil
older
individu
found
deficit
express
tolllik
receptor
tlr
opson
phagocytosi
bacteri
kill
chemotact
respons
product
cytokin
chemokin
howev
age
seem
factor
account
differ
observ
studi
sinc
comparison
elderli
year
old
vs
nonelderli
patient
show
signific
differ
neutrophil
function
paramet
result
shown
anoth
limit
studi
inclus
patient
condit
potenti
affect
immunocompet
statu
presenc
comorbid
congest
heart
failur
cerebrovascular
diseas
copd
character
presenc
chronic
inflammatori
respons
neoplasia
therapeut
corticosteroid
use
may
result
sever
defect
function
immun
cell
also
activ
sever
immunoregulatori
mechan
includ
immunosuppress
cytokin
myeloid
lymphocyt
regulatori
cell
studi
need
better
understand
contribut
immun
defect
associ
comorbid
local
lung
respons
cap
regard
target
immunosuppress
mechan
particularli
lung
may
thu
potenti
benefit
high
risk
cap
patient
common
pathophysiolog
explan
inflammatori
respons
patient
sever
cap
propos
respons
invad
microorgan
first
initi
exagger
local
inflammatori
respons
excess
local
inflammatori
respons
fill
pulmonari
compart
spill
cytokin
inflamm
system
circul
gener
system
inflammatori
respons
associ
sever
cap
data
studi
seem
indic
exagger
local
inflammatori
respons
associ
sever
cap
contrari
patient
sever
cap
significantli
lower
pulmonari
inflammatori
respons
relat
patient
nonsever
cap
agreement
literatur
found
patient
sever
cap
significantli
higher
level
system
inflamm
initi
step
reach
system
inflamm
may
excess
local
pulmonari
inflamm
hypothes
patient
abl
produc
adequ
local
pulmonari
respons
abl
contain
microorgan
develop
exagger
system
respons
present
nonsever
cap
first
respons
local
pulmonari
level
suffici
due
local
level
immun
defici
second
respons
system
level
elicit
last
attempt
control
infect
paradigm
correct
patient
sever
cap
dual
inflammatori
respons
low
pulmonari
respons
high
system
respons
therapeut
manag
inflamm
patient
sever
cap
differ
lung
system
circul
financi
disclosur
dr
uriart
support
nih
grant
